UK finalizes major veterinary reforms targeting pet care costs

The UK’s competition watchdog has now moved from proposal to action in its overhaul of veterinary services for household pets, publishing final reforms on March 24, 2026, that are meant to make pricing clearer, reduce barriers to buying medicines elsewhere, and tighten oversight of veterinary businesses. The Competition and Markets Authority said the changes will begin coming into force later this year, with legally binding measures covering price lists, prescription fee caps, ownership disclosure, written cost estimates, complaints processes, and new comparison tools for pet parents. (gov.uk)

The final package caps off an investigation that began with a sector review in September 2023 and formally became a market investigation in May 2024 after the CMA said it had concerns about competition, consumer choice, and rising costs. The inquiry drew an unusually large response, with 56,000 submissions from the public and veterinary sector. In its final findings, the CMA said average veterinary prices rose 63% between 2016 and 2023, compared with 32% general inflation, and that many pet parents still lacked basic information on who owns their practice, what treatment might cost, and whether medicines could be purchased more cheaply online. (gov.uk)

The new rules are detailed and operationally significant. Practices will have to publish comprehensive price lists for standard services, diagnostics, prescriptions, euthanasia, and cremation options; disclose whether they are part of a corporate group; provide written estimates for treatments expected to cost £500 or more except in emergencies; and issue itemized bills. On medicines, practices must tell pet parents they can request a written prescription, provide paper prescriptions before the client leaves or email them within 48 hours, and stay within the new fee caps of £21 for the first medicine and £12.50 for each additional medicine, indexed to inflation. The CMA also wants RCVS “Find a Vet” data to support comparison tools so pet parents can compare local practices more easily. (gov.uk)

The reforms go beyond front-desk transparency. The CMA said practices must have written policies that support vets in giving independent and impartial advice, must maintain an accessible in-house complaints process, and may have to engage in mediation when complaints can’t be resolved internally. It also targeted out-of-hours contracting, saying providers should no longer be able to impose unreasonably long notice periods that make it hard for practices to switch. Separately, the CMA endorsed broader government reform of veterinary legislation, arguing that the current regime is outdated because it regulates individual professionals but not veterinary businesses themselves. (gov.uk)

Reaction from the profession has been measured rather than celebratory. The RCVS said it broadly welcomes many of the remedies and the enhanced role it will play in monitoring compliance, while cautioning that some recommendations could create problems, including a strong focus on anti-parasiticide pricing without enough weight on suitability, environmental considerations, and public health. The BVA also said it supports most of the final measures, especially those tied to transparency and consumer choice, and noted that the CMA softened or dropped some earlier ideas after sector feedback, including raising the proposed prescription cap from £16 to the final £21 for the first medicine and extending prescription delivery to 48 hours. (rcvs.org.uk)

Why it matters: For veterinary professionals, the headline isn’t just that the UK wants lower and clearer prices. It’s that competition policy is now directly reshaping practice operations. Client communication, medicine dispensing, website content, complaints handling, and even internal safeguards around clinical autonomy are moving into a more formal compliance framework. That could improve trust with pet parents and reduce confusion at the point of care, but it also adds administrative load and may put pressure on business models that have historically relied on medicine margins or less standardized pricing. The CMA’s own framing is notable here: it explicitly said veterinary professionalism and commitment to animal welfare are not in question, while arguing that structural market problems, especially in a corporatized sector, require intervention. (gov.uk)

For US veterinary leaders, the UK story is worth watching because it offers a live regulatory test case for issues that are increasingly familiar elsewhere: consolidation, price opacity, online pharmacy competition, and the tension between consumer protection and practice viability. The CMA found that average prices at five large veterinary groups were higher than those at independents between January 2023 and July 2024 in one analysis, and it is explicitly using transparency and business-level accountability as remedies rather than relying on professional regulation alone. If these reforms improve trust and shopping behavior without destabilizing care delivery, they could influence how other markets think about veterinary oversight. (assets.publishing.service.gov.uk)

What to watch: The market investigation itself is over, but the implementation phase now begins. The CMA says it has six months, until September 23, 2026, to finalize binding orders, after which most remedies will phase in over three to 12 months, with extra time for smaller practices. The practical questions now are whether the RCVS can stand up monitoring and comparison functions smoothly, how practices adapt their workflows without disrupting care, and whether the reforms actually lower costs for pet parents or simply redistribute where those costs show up. (gov.uk)